Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (2): 76-80.DOI: 10.3969/j.issn.1673-8640.2017.02.002

• Orginal Article • Previous Articles     Next Articles

Plasmocyte immuno-phenotype characteristics of 37 cases of CD45-positive multiple myeloma

LIU Shuai, LI Zhaobo, ZHANG Fan, WANG Ningning, YUE Baohong   

  1. Department of Clinical Laboratory,the First Affiliated Hospital of Zhengzhou University/Faculty of Laboratory Medicine,Zhengzhou University,Zhengzhou 450052,Henan,China
  • Received:2016-03-21 Online:2017-03-30 Published:2017-03-30

Abstract:

Objective To investigate the plasmocyte immuno-phenotype characteristics of CD45-positive(CD45+) multiple myeloma(MM) and its difference with the plasmocyte immuno-phenotype characteristics of CD45-negative(CD45-)MM,and to analyze the correlation of CD45 expression with MM clinical characteristic.Methods The data of 192 MM patients were reviewed for immuno-phenotype analysis.Results According to CD45 expression,192 MM patients were classified into CD45+ MM(CD45 average fluorescence intensity on plasma cells >102) group(37 cases) and CD45- MM group(155 cases). In CD45+ MM group,the positive rates of CD138,CD38,CD19,CD56,CD20,CD71,CD117 and CD33 were 83.8%,97.3%,32.4%,64.9%,21.6%,51.4%,35.1% and 24.3%. The positive rates of κ and λ light chains were 45.9%. There was 8.2% with no light chain expression. The positive rates of CD19,CD71 and CD138 had statistical significance between the 2 groups(P<0.05). There was no statistical significance between the 2 groups for the positive rates and light chain expression of CD38,CD56,CD20,CD117 and CD33(P>0.05). Conclusions For CD45+ MM patients,their CD19 and CD71 positive rates increase,and CD138 positive rate decreases. CD45+ MM cells may be in the early differentiation stage of plasma cells.

Key words: CD45, Immuno-phenotype, Multiple myeloma

CLC Number: